Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Updated phase I results for MSC-2156119J in advanced solid tumors

Oct. 9, 2014

Novel FabI inhibitors with promising activity against staphylococcal infections

Oct. 9, 2014

BNN-93, a novel neuroprotective ocular solution

Oct. 8, 2014

SNP signature linked to response to glatiramer in patients with MS

Oct. 8, 2014

Interim phase II results for squalamine lactate plus ranibizumab in neovascular AMD

Oct. 8, 2014

MicroRNA identified as a biomarker target for MS

Oct. 8, 2014

Phase I results presented for the new PET tracer [18F]-FSPG

Oct. 8, 2014

Novel selective prostanoid EP2 receptor agonist shows promise in preclinical studies

Oct. 7, 2014

Early clinical results for KRN-23 as potential treatment of X-linked hypophosphatemia

Oct. 7, 2014

Galapagos describes discovery of FFA2 antagonist in development for ulcerative colitis

Oct. 7, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...